Nogo-66 Receptor Antagonist Peptide (NEP1-40) Administration Promotes Functional Recovery and Axonal Growth After Lateral Funiculus Injury in the Adult Rat
Open Access
- 1 May 2008
- journal article
- research article
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 22 (3), 262-278
- https://doi.org/10.1177/1545968307308550
Abstract
Objective. The myelin protein Nogo inhibits axon regeneration by binding to its receptor (NgR) on axons. Intrathecal delivery of an NgR antagonist (NEP1-40) promotes growth of injured corticospinal axons and recovery of motor function following a dorsal hemisection. The authors used a similar design to examine recovery and repair after a lesion that interrupts the rubrospinal tract (RST). Methods. Rats received a lateral funiculotomy at C4 and NEP1-40 or vehicle was delivered to the cervical spinal cord for 4 weeks. Outcome measures included motor and sensory tests and immunohistochemistry. Results. Gait analysis showed recovery in the NEP1-40-treated group compared to operated controls, and a test of forelimb usage also showed a beneficial effect. The density of labeled RST axons increased ipsilaterally in the NEP1-40 group in the lateral funiculus rostral to the lesion and contralaterally in both gray and white matter. Thus, rubrospinal axons exhibited diminished dieback and/or growth up to the lesion site. This was accompanied by greater density of 5HT and calcitonin gene-related peptide axons adjacent to and into the lesion/matrix site in the NEP1-40 group. Conclusions. NgR blockade after RST injury is associated with axonal growth and/or diminished dieback of severed RST axons up to but not into or beyond the lesion/matrix site, and growth of serotonergic and dorsal root axons adjacent to and into the lesion/matrix site. NgR blockade also supported partial recovery of function. The authors' results indicate that severed rubrospinal axons respond to NEP1-40 treatment but less robustly than corticospinal, raphe-spinal, or dorsal root axons.Keywords
This publication has 74 references indexed in Scilit:
- Response to Correspondence: Kim et al., “Axon Regeneration in Young Adult Mice Lacking Nogo-A/B.” Neuron 38, 187–199Neuron, 2007
- The Nogo–Nogo Receptor Pathway Limits a Spectrum of Adult CNS Axonal GrowthJournal of Neuroscience, 2006
- Delayed Nogo receptor therapy improves recovery from spinal cord contusionAnnals of Neurology, 2006
- Extracellular regulators of axonal growth in the adult central nervous systemPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2006
- Immunosuppression with Either Cyclosporine A or FK506 Supports Survival of Transplanted Fibroblasts and Promotes Growth of Host Axons into the Transplant after Spinal Cord InjuryJournal of Neurotrauma, 2005
- TAJ/TROY, an Orphan TNF Receptor Family Member, Binds Nogo-66 Receptor 1 and Regulates Axonal RegenerationNeuron, 2005
- A TNF Receptor Family Member, TROY, Is a Coreceptor with Nogo Receptor in Mediating the Inhibitory Activity of Myelin InhibitorsNeuron, 2005
- LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complexNature Neuroscience, 2004
- p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgpNature, 2002
- A technique for the study of spatiotemporal aspects of paw contact patterns, applied to rats treated with a TRH analogueBehavior Research Methods, Instruments & Computers, 1992